Drug Discovery and the Market Today: Video Exclusive with Dr. David Elder, GSK
06/11/2010
Rate this Video:
(5.0 Stars | 4 Votes)
David Elder | drug discovery | stability testing | solubility | amorphous forms | genotoxic and carcinogenic impurities | externalization
David Elder | drug discovery | stability testing | solubility | amorphous forms | genotoxic and carcinogenic impurities | externalization
Dr. David Elder, the Externalization Director for GlaxoSmithKline, talks exclusively to Pharma IQ on his perspective across the industry, including CROs, regulations, and strategising for efficiency.
-
Recent Developments in Optimised Forecast Accuracy, Sales and Operations Planning at Merck Serono -
BHC- Product Supply: Pipeline Transparency & Risk Asssessment -
Safety Assessment of Novel Respiratory Delivery Systems: Lessons from the Exubera® Development Program -
Contractor Management -
Rolling Out a New Cold Chain Solution to Maximise Validation and Process Efficiency -
Drug Discovery and the Market Today Part 4: Developing Amorphous Forms -
Drug Discovery and the Market Today Part 5: Considering Genotoxic and Carcinogenic Impurities -
Drug Discovery and the Market Today Part 2: Critical Thoughts on Stability -
Drug Discovery and the Market Today Part 3: The Focus on Solubility -
Drug Discovery and the Market Today Part 1: An Overview of Externalisation in the Pharma Industry
You Should Check Out:
* = required.
Not a member yet? Sign up
Advertisement
Events of Interest
-
Innovation in Clinical Design, Analysis and Reporting
Venue to be confirmed, London, UK
December 7- 8, 2010 -
Developing IP Strategies for Crystalline Forms
CCT Venues Canary Wharf, London, UK
December 6- 8, 2010 -
ELNs: Advanced Laboratory Solutions
Marriott Hotel, Amsterdam, The Netherlands
September 27- 29, 2010 -
9th Polymorphism & Crystallization Scientific Forum
Philadelphia, PA
October 25- 27, 2010
You Might Also Like
-
Implementing Thermal Processing Technologies for the Production of Amorphous Solid Dispersions
Amorphous pharmaceutical materials are now being recognised as an attractive alternative route for solid...Read more
Helen Winsor
-
Getting to Grips with Stability Testing and Regulatory Compliance
Find out more about the challenges in pre-and post-release stability testing and formulation. In this...Read more
Helen Winsor
-
The Challenges of Amorphous Solid Dispersion Production: A Hoffman La Roche Perspective
Dr. Dave Miller, Senior Principal Scientist at Hoffmann La Roche, shares his views on how to optimise
Pharma IQ
-
FDA Representative Gives Insights into Success and Accuracy in Genotoxicity and Carcinogenicity Testing in Exclusive Podcast Interview
Pharma IQ has interviewed Dr. Timothy Robison, Pharmacology and Toxicity Reviewer at the US Food & Drug...Read more
Pharma IQ News
|
Reach Pharma professionals through cost-effective marketing opportunities to deliver your message, position yourself as a thought leader, and introduce new products, techniques and strategies to the market.
Learn More >> Join today and interact with a vibrant network of pharma professionals, keeping up to date with the pharma industry by accessing our wealth of Pharma articles, videos, online seminars, live conferences and more. Sign Up Today! |
| Pharma IQ, a division of IQPC 2010 All rights reserved.Use of this site constitutes acceptance of our User Agreement and Privacy Policy. Careers With IQPC | Contact Us | Unsubscribe to Bizo |
|